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The impact of self-monitoring in chronic
illness on healthcare utilisation: a
systematic review of reviews
Hayley McBain1,2, Michael Shipley3 and Stanton Newman1*
Abstract
Background: Self-management interventions have been found to reduce healthcare utilisation in people with
long-term conditions, but further work is needed to identify which components of these interventions are most
effective. Self-monitoring is one such component and is associated with significant clinical benefits. The aim of this
systematic review of reviews is to assess the impact of self-monitoring interventions on healthcare utilisation across
a range of chronic illnesses.
Methods: An overview of published systematic reviews and meta-analyses. Multiple databases were searched
(MEDLINE, CINAHL, PsycINFO, EMBASE, AMED, EBM and HMIC) along with the reference lists of included reviews. A
narrative synthesis was performed, accompanied by calculation of the Corrected Cover Area to understand the
impact of overlapping primary research papers.
Results: A total of 17 systematic reviews and meta-analyses across three chronic conditions, heart failure, hypertension
and chronic obstructive pulmonary disease, were included. Self-monitoring was associated with significant reductions
in hospitalisation and re-admissions to hospital.
Conclusions: Self-monitoring has the potential to reduce the pressure placed on secondary care services, but this may
lead to increase in services elsewhere in the system. Further work is needed to determine how these findings affect
healthcare costs.
Keywords: Self-monitoring, Chronic illness, Healthcare utilization, Complex interventions, Hospitalization, Systematic
review, Meta-analysis
Background
Self-management has been defined as an individual’s
ability to manage the clinical and psychosocial conse-
quences, along with the lifestyle changes inherent in liv-
ing with a chronic condition [1]. Chronic disease self-
management interventions, can lead to small, but statis-
tically significant reductions in health service utilisation
[2]. These interventions are however, complex in nature
as they consist of a number of interacting components
[3]. These interacting components, also known as behav-
iour change techniques [4], are the active ingredients
that bring about the desired change in behaviour and
improvements in outcomes. In order to optimise the ef-
fectiveness of self-management interventions there is a
need to determine which specific components of these
interventions are most effective in reducing healthcare
usage [2].
One such component is self-monitoring, the founda-
tion for self-management [5]. Self-monitoring in the
context of chronic illness has been defined as the patient
undertaking one or more of the following activities (i)
self-measurement of vital signs, symptoms, behaviour or
psychological well-being; (ii) self-interpretation of this
data; or (iii) self-adjustment of medication, treatment,
lifestyle or help-seeking behaviour as a result of self-
awareness and/or self-interpretation [6, 7]. The clinical
benefits of self-monitoring in chronic illness include re-
ductions in HbA1c [8–12], improvements in blood
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pressure [13–15], and reductions in mortality and ad-
verse events [16]. As a result, self-monitoring is part of
recommended practice in a number of chronic condi-
tions [17–21]. For example National Institute for Health
and Care Excellence (NICE) guidelines recommend
home blood pressure monitoring in hypertension [17],
self-monitoring and self-management of vitamin K an-
tagonists in atrial fibrillation [18] and self-monitoring of
blood glucose in diabetes [20, 21]. This has been enabled
by more open access to clinical data and the introduc-
tion of technology that allows patients to take measure-
ments that would have otherwise required visits to a
healthcare setting.
The impact of self-monitoring on healthcare utilisation
is however unknown, but nevertheless an important out-
come for interventions that are aimed at a population
who are likely to require significant healthcare resources
[22]. The aim of this systematic review is to assess the
impact of interventions whose primary function is self-
monitoring, on healthcare utilisation, across a range of
chronic conditions.
Methods
Inclusion and exclusion criteria
Study design
As the volume of literature in this area is large and a
number of systematic reviews and meta-analyses have
been published, this overview included either systematic
reviews or meta-analyses only. Primary research studies
were excluded. If the review contained a synthesis of
qualitative studies or secondary data (i.e. other system-
atic reviews or meta-analyses) this content was not ex-
tracted. The search was limited to articles in English, but
conducted in any country.
Population
Adults living with a chronic disease, defined as a phys-
ical illness that is prolonged in duration, does not often
resolve spontaneously, and is rarely cured completely
[23]. Reviews that included more than one long-term
physical health condition were excluded in order for
data to be summarised within a long-term condition.
Intervention
Patient self-monitoring had to be the focus of the re-
view or be an element of all interventions by virtue of
the nature of that intervention (i.e. telemonitoring).
Self-monitoring was defined as the patient undertaking
one or more of the following activities (i) Awareness:
Self-measurement of vital signs, symptoms, behaviour
or psychological well-being, (ii) Interpretation: Self-
interpretation of vital signs, symptoms, behaviour or
psychological well-being; or (iii) Response: Self-adjustment
of medication, treatment, lifestyle or help-seeking behaviour
as a result of self-awareness and/or self-interpretation
[6, 7]. Delivered by any method.
Outcome
The review had to synthesize the evidence in relation to
healthcare utilisation as a primary or secondary out-
come. Reviews that were restricted to clinical outcomes,
psychosocial outcomes, acceptability, cost-effectiveness
or feasibility were excluded from this overview, unless
data relating to healthcare utilisation could be extracted.
Data sources and search strategy
EBSCOHost was used to search CINAHL Plus® full text
(1937–2014), MEDLINE with full text (1948 to February
5, 2014) and PsycINFO (from 1806–2014). OVID Online
was used to search EMBASE (1996–2014 Week 06), Al-
lied and Complementary Medicine (1985 to February
2014), Evidence Based Medicine Reviews (All) 1 and
Health Management Information Consortium (1979 to
November 2013). Key words or Medical Subject Head-
ings (MeSH) terms were used, coupled with Boolean lo-
gical operators, for both self-monitoring and systematic
review.
A full list of search terms, by database, can be
found in Additional file 1. Searches were performed
in February 2014 and reviews could be have been pub-
lished at any time. Reference lists of relevant articles were
also searched in order to identify additional reviews.
Review selection
After the removal of duplicates and reviews not pub-
lished in English, one author assessed all titles for rele-
vance. Those clearly not meeting the inclusion and
exclusion criteria were removed and full reviews thought
to be of relevance were retrieved for assessment against
the inclusion and exclusion criteria. These were assessed
by one author and then those judged to be relevant
assessed by a second reviewer according to the outlined
criteria. Any disagreements were discussed with a third
reviewer and resolved by consensus.
Data extraction
The following characteristics of the reviews were ex-
tracted: illness or disease type, self-monitoring activity
(i.e. awareness/interpretation/response), type of review,
search strategy, inclusion and exclusion criteria, quality
assessment, data extraction procedure, total number of
studies and participants, author’s conclusions and inter-
pretations. The relevant data were extracted and re-
corded by one author; independent data extraction was
also performed on a random sample of 25 % of reviews
by a second reviewer. Any disagreements were then dis-
cussed with a third member of the team and resolved by
consensus.
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Synthesis
No statistical analysis or meta-analysis were con-
ducted. This review of reviews comprises a narrative
synthesis of the available systematic reviews and
meta-analyses in this area. For clarity the term ‘pri-
mary research studies’ refers to the articles found
within the included reviews. As many primary re-
search studies are included in more than one review
the overall results and conclusions of an overview can
be biased. To assess and understand the potential im-
pact of this overlap, the degree of overlap within and
between reviews was measured using the validated
Corrected Cover Area (CCA) method [24]. A CCA
score of 0–5 is considered slight overlap, 6–10 mod-
erate, 11–15 high and >15 very high [24]. In accord-
ance with reporting guidelines for systematic reviews,
a Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) [25] checklist can be
found in Electronic Additional file 2.
Review quality
The 11-item Assessment of Multiple Systematic Reviews
(AMSTAR) checklist was used to assess the quality of
each of the included reviews. The measure possesses sat-
isfactory inter-observer agreement, reliability, construct
validity and feasibility [26, 27]. The quality score ranges
from 0 (lowest quality) to 11 (highest quality).
Results
A total of 2114 references were retrieved. After exclu-
sions based on title alone 320 full articles were retrieved
and after screening 17 articles reporting 16 different sys-
tematic reviews or meta-analyses were selected for pos-
sible inclusion (Fig. 1). A list of excluded reviews can be
found in Additional file 3. One review had been pub-
lished twice, as a Cochrane review and again as peer
reviewed journal article [28, 29]. Both containing the
same data, only the journal article was included [28].
One additional review [30] was identified as a result of
Fig. 1 PRISMA Flowchart
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reference list searches, resulting in a total of 17 reviews
in this overview. Of the 320 full text articles reviewed by
two authors, there was disagreement on 17 (5.31 %) of
these, discussion between the two reviewers resolved 14
of these and 3 were taken to the third reviewer for
discussion.
Review characteristics
The characteristics of the included reviews can be found
in a table in Additional file 4. Table 1 provides a sum-
mary of this data, with the most frequently evaluated in-
terventions, measures of healthcare utilization and
monitored data. The reviews synthesised intervention ef-
fectiveness across three chronic conditions; hypertension
(n = 2), chronic obstructive pulmonary disease (COPD)
(n = 2) and heart failure (n = 13). The overall CCA across
all five long-term conditions was 4.10 %, which repre-
sented slight overlap [23]. There was however, significant
variation between long-term conditions (Table 1). Eight
reviews included only randomised controlled trials
(RCT), the remaining reviews included a combination
of study designs.
Intervention characteristics
Electronic Additional file 5 is a table with detailed infor-
mation about the characteristics of the interventions. In
COPD the interventions were action planning and tele-
healthcare and in both hypertension and heart failure
telemonitoring. Self-monitoring was facilitated through
the use of technology in 15 reviews, in which patients
took measurements and then transmitted data to a
healthcare professional for interpretation and adjust-
ment. Assessing the interventions according to the three
components of self-monitoring: awareness, interpret-
ation and response [6, 7]. In only two reviews, one of
self-management in heart failure [31] and the other ac-
tion planning in COPD [32], did interventions consist of
all three components. In all other reviews only aware-
ness was achieved.
Control conditions
On the whole the articles that included studies with a
control group generally provided a poor description of
the content. Two articles failed to detail the content of
any control groups [33, 34]. For a majority there was no
consistency in what the intervention group was com-
pared to and for others they were compared to a mix-
ture of usual care and/or an active control group. In
most cases however, the definition of usual or standard
care was not described or where it was it was not con-
sistent across primary research studies.
Assessment of review quality
The methodological quality of the 17 reviews varied
(Fig. 2), but was generally good (median score = 5). The
most common methodological problems were failure to
report conflicts of interest, lack of integration of study
quality into the conclusions of the review, exclusion of
studies based on their publication status, not providing a
list of included or excluded studies and not assessing the
likelihood of publication bias.
Intervention effectiveness
Whilst the reviews in heart failure and COPD synthe-
sised the evidence in relation to a range of healthcare
utilisation outcomes, the two reviews in hypertension re-
ported the effects in relation to GP attendance only.
Hospitalisation
Thirteen of the 17 reviews reported the effects of either
telehealth (n = 12) or action planning (n = 1) on disease-
specific and/or all-cause hospitalisation, 11 in heart fail-
ure and 2 in COPD.
The one article on action planning was a low quality
meta-analysis, in which patients with COPD were ac-
tively involved in adjusting their treatment or seeking
medical advice in response to their symptoms. This
meta-analysis failed to find any significant effect on rates
of hospitalisation (n = 2, weighted mean difference
Table 1 Summary of included systematic reviews and meta-analyses
Condition No. of
reviews
No. of primary
research studies
Intervention Healthcare utilization
measure (s)
Monitored
data
Purpose of self-monitoring CCAa
Hypertension 2 26 Telemonitoring GP attendance Blood
pressure
To increase adherence to
hypertensive medication,
reduce clinical inertia and
provide information about
the efficacy of treatment in
order to alter medication dosage.
15.38 %
COPD 2 15 Action planning
& telehealthcare
Hospitalisation, ER visits,
GP attendance, discharge
to higher levels of care.
Symptoms PEF is measured and recorded
daily in order to adjustment
medication.
0 %
Heart failure 13 160 Telemonitoring Hospitalisation, readmission
rates, length of stay, ER visits,
home visits, outpatient visits,
Symptoms,
weight
Frequent monitoring will allow
for early signs and symptoms
of decline.
6.67 %
a
CCA Corrected cover area, bINR International normalized ratio
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(WMD) = 0.16, 95 % Confidence Interval (CI) -0.09–
0.42) [32] and all of the primary research studies in this
review had methodological limitations, increasing the
risk of bias.
The reviews of telehealth were more positive. Seven
meta-analyses evaluated the evidence with regards to
telemonitoring and/or structured telephone support in
either COPD or heart failure. The use of technology
to support self-monitoring was associated with up to
27 % reduction in total all-cause or disease-specific
hospitalisations compared to control conditions (see
Table 2 for specific results) [28, 35–40]. All these re-
views were rated of moderate or high quality. The
quality of the primary research studies within them
however, ranged from introducing a low risk of bias
[35, 36] to introducing a significant amount of meth-
odological bias [29, 38, 40]. Whilst human-to-human
structured telephone support led to a significant re-
duction in heart failure-related hospitalisations, the
one review on human-to-machine structured tele-
phone support failed to have any effect [35]. In con-
trast to what might be expected, subgroup analyses
within this moderate quality review indicated that tel-
emonitoring with medical support available only dur-
ing office hours was associated with a greater
reduction in hospitalisations than when medical sup-
port was available 24/7 [35].
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Fig. 2 Distribution plot of the quality of review articles
Table 2 Results of the meta-analyses in relation to hospitalisation for technology enabled self-monitoring
Study Condition Comparisons Results
McLean, 2011 COPD Telehealthcare versus control All-cause hospitalisation: OR = 0.46, 95 % CI
0.33–0.65, p < 0.00001, n = 4
Clark, 2007 Heart failure TM or STS versus usual care All-cause hospital admission: STS (RR = 0.94, 95 % CI
0.87 –1.02, p = 0.15, n = 7). TM (RR = 0.95, 95 % CI
0.89–1.02, p = 0.83, n = 2). HF-related hospitalization:
STS (RR = 0.78, 95 % CI 0.68–0.89, p = 0.0003, n = 9)
TM (RR = 0.79, 95%CI 0.69–0.89, p = 0.45, n = 1).
Klersy, 2009 Heart failure RPM versus control All-cause hospitalisation: RCT (RR = 0.93; 95 % CI
0.73–0.95; p = 0.030, n = 11) Cohort studies (RR = 0.52;
95 % CI 0.28–0.96; p < 0.001, n = 3) CHF-related
hospitalisations: RCT (RR = 0.71; 95 % CI 0.64–0.80;
p < 0.001, n = 13) when compared with usual care.
Polisena, 2009 Heart failure TM versus usual care No of patients hospitalised all-cause: RR = 0.77; 95 % CI
0.65–0.90, n = 4
Inglis, 2010 Heart failure STS or TM versus usual care All-cause hospitalisation: STS (RR = 0.91, 95 % CI
0.85–0.99, p = 0.02, n = 11) and TM (RR = 0.92, 95 % CI
0.84–0.99, p = 0.02, n = 8). CHF-related hospitalisation –
STS (RR = 0.77, 95 % CI 0.68–0.87, p < 0.0001, n = 13)
and TM (RR = 0.79, 95 % CI 0.67–0.94, p = 0.008, n = 4)
Clarke, 2011 Heart failure TM versus usual care All-cause hospital admission: RR = 0.99, 95 % CI
0.88–1.11, p = 0.84, n = 6). CHF-related hospital
admission: RR = 0.73, 95 % CI 0.62–0.87, p = 0.0004,
n = 6)
Pandor, 2013 Heart failure TM with medical support in
office hours (TM Office), TM
with medical support 24/4
(TM 24/7), Human to machine
STS (STS HM) or Human to
human STS (STS HH) versus
control
All-cause hospitalisation: TM Office (HR: 0.75, 95 % CrI:
0.49–1.10, p = NR, n = 6). TM 24/7 (HR: 0.81, 95 % CrI:
0.33–2.00, p = NR, n = 1). STS HM (HR: 1.06, 95 % CrI:
0.44–2.53, p = NR, n = 1). STS HH (HR: 0.97, 95 % CrI:
0.70, 1.31, p = NR, n = 9). CHF-related hospitalisation:
TM Office (HR: 0.95, 95 % CrI: 0.70, 1.34, p = NR, n = 3).
STS HM (HR: 1.03, 95 % CrI: 0.66, 1.54, p = NR, n = 1).
STS HH (HR: 0.77, 95 % CrI: 0.62, 0.96, p = NR, n = 8).
Turnock, 2005 COPD Action planning versus usual care All-cause hospitalisation: WMD = 0.16, 95 % CI −0.09–0.42,
p = 0.21, n = 2
TM telemonitoring, STS structured telephone support, RR relative risk, OR odds ratio, HR hazard ratio, WMD weighted mean difference, CI confidence interval, Crl
Credible interval, NR not reported
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Five further systematic reviews, of either low or mod-
erate quality, concluded that there was a positive trend
towards a reduction in all-cause and disease-specific
hospitalisation in favour of telemonitoring for patients
with heart failure [30, 33, 41–43]. Only two of these sys-
tematic reviews rated the quality of the primary research
studies, both suggested that the studies were of good
quality [30, 33].
Readmissions
Rates of readmission in heart failure were reported in
one meta-analysis and three systematic reviews. The
meta-analysis, of moderate quality, found that self-
management in which patients were taught to seek med-
ical assistance in response to their symptoms, reduced
the odds of all-cause and disease-specific readmission by
up to 54 % (n = 5, Odds Ratio (OR) = 0.59, 95 % CI
0.44–0.80; n = 3, OR = 0.44, 95 % CI 0.27–0.71; respect-
ively) [31]. The quality of the primary research studies
included in this review however, varied significantly.
Conclusions of the three systematic reviews, which were
either of low or moderate quality, indicated an associ-
ation between telemonitoring and fewer readmissions to
hospital [42–44]. As result of the quality of the primary
research studies in these systematic reviews the authors
concluded that further, more methodological robust tri-
als were needed before widespread adoption of telemoni-
toring should take place.
Length of hospital stay
The conclusions drawn by the authors of eight system-
atic reviews in heart failure, in relation to the number of
days patients spent in hospital, were mixed. Telemoni-
toring was associated with a reduction in the length of
hospital stay in three low to moderate quality systematic
reviews; both within the intervention group over time
and also when compared to a control group [42–44].
Only one review [44] rated the strength of the evidence,
which was considered to be very heterogeneous. The five
remaining moderate to high quality systematic reviews
failed to find an association between telemonitoring and
time spent in hospital [30, 35–37, 40]. All reviews judged
the primary research studies to be of least fair quality
with a low risk of bias. Except one, which failed to rate
quality of the primary research studies [37].
Accident and emergency (A & E) attendance
Seven reviews; three meta-analyses and four systematic
reviews synthesised the evidence in relation to A & E at-
tendance. Action planning in COPD, which involved pa-
tients measuring, interpreting and responding to their
data, was not found to have any significant effect on visits
to A & E in one meta-analysis (n = 2, WMD= −0.01, 95 %
CI −0.12–0.10, p = 0.85) [32]. However, the primary
research studies in this review did include some risk of
bias and the review itself was of low quality.
There was a mixed picture in regards to telehealth in
heart failure, further muddied by the poor quality of
these reviews. Whilst a meta-analysis of telemonitoring
in heart failure failed to find any effects on A & E at-
tendance (n = 4, Risk Ratio (RR) = 1.04, 95 % CI 0.86–
1.26, p = 0.67) [37], the systematic reviews in heart fail-
ure [30, 40, 42, 43] concluded that telehealth was associ-
ated with fewer all-cause and disease-specific A & E
visits. Within these reviews the strength of the evidence
was either rated as fair [30, 40] or was not rated at all
[37, 42, 43]. More promisingly, a moderate quality meta-
analysis of telehealth in COPD [28] found that odds of
attending the A & E department were significantly re-
duced in the telehealthcare compared to control group
(n = 3, OR = 0.27, 95 % CI 0.11–0.66, p = 0.005), however,
a majority of the primary research studies in the review
included significant risk of bias.
Outpatient visits
One systematic review, of moderate quality, assessed the
impact of telemonitoring in heart failure [40] and con-
cluded that home telemonitoring was associated with in-
creased visits to specialist outpatient services.
GP visits
The impact of self-monitoring on the frequency of GP
visits was reported in one meta-analysis and two system-
atic reviews, all rated low quality. The meta-analysis in
COPD found no significant difference between action
planning and usual care in scheduled (n = 1, mean differ-
ence (MD) = −0.50, 95 % CI −4.06–3.06, p = 0.78) or un-
scheduled GP visits (n = 1, MD = −0.20, 95 % CI −1.55–
1.15, p = 0.77) [32]. The primary research studies in this
review also had a number of methodological limitations.
The two systematic reviews in hypertension, one of
home-based blood pressure monitoring [34] and the
other of telemonitoring [45], both found no impact on
GP visits. Neither of these systematic reviews assessed
the quality of the primary research studies.
Home visits
Two systematic reviews in heart failure reported weak
and inconsistent effects for telemonitoring on the fre-
quency of home visits [40, 43]. Although one of these re-
views suggested a reduction in home visits, there was no
quality assessment of the primary research studies and
the review itself was of poor quality [43]. The other sys-
tematic review, of moderate quality, concluded that
home telemonitoring was associated with a greater num-
ber of home care visits [40].
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Discussion
This overview of systematic reviews and meta-analyses
has examined the impact of self-monitoring on health
service utilisation. It is based on a methodical and exten-
sive literature search, and includes a range of chronic
conditions and an assessment of review quality. A total
of 17 reviews were synthesized in three long-term condi-
tions: COPD, hypertension and heart failure. In sum-
mary, interventions that include self-monitoring can
lead to significant reductions in specific areas of health-
care usage, but this is dependent on the chronic illness.
An increase in contact with healthcare professionals was
also found, specifically in relation to outpatient and
home visits. The quality of the primary research studies
included in these reviews, and the quality of the reviews
themselves was variable and this may potentially bias
these conclusions.
Whilst there was evidence to suggest that telemonitor-
ing was associated with fewer visits to A & E, either the
reviews themselves were of low quality or the quality of
the primary research studies included within them intro-
duced a significant risk of bias, making clear conclusions
problematic. The results were more promising in regards
to admissions to hospital, which were found to decrease
significantly as a result of self-monitoring. These find-
ings were most evident in patients with heart failure,
where many primary research studies and reviews had
been conducted, but also in COPD. Thus reflecting the
findings from the broader self-management literature
[2]. In both heart failure and COPD, the significant re-
ductions found in disease-specific and all-cause hospital-
isation, and readmission rates, were evidenced only in
evaluations of telemonitoring and structured telephone
support. Both human-to-human structured telephone
support and telemonitoring interventions accompanied
by medical support during office hours were found to be
particularly advantageous in reducing hospitalization
and readmission rates in the short- and long-term. Al-
though the mechanisms of this effect are unclear, tech-
nology supported by direct communication with a
healthcare professional, rather than automated feedback
alone, may allow for more immediate personalised ac-
tion to be taken, reducing the likelihood of hospitalisa-
tion. There was however, significant variation in the
quality of the primary research studies included in these
reviews. This variation could be attributed in part to the
differing methods used to assess study quality, but could
also indicate that more methodological robust trials are
needed to confirm these findings.
Once admitted to hospital the effects of self-
monitoring were only explored in patients with heart
failure, and conclusions were inconsistent. Whilst some
reviews found that self-monitoring interventions led to a
significant reductions in days spent in hospital, others
failed to find any such effect. The quality of the reviews
themselves, and the primary research studies included
within them, suggest that any conclusion that self-
monitoring leads to reductions in days spent in hospital
are not justified at this time.
Visits to the GP were unaffected by self-monitoring,
however the quality of this evidence was poor. It was
also unclear if the primary aim of these interventions
was to reduce attendance in primary care or to ensure
that any reductions in the use of secondary care services
did not lead to a redirection of help-seeking in primary
care. As visits to primary care were unaffected, it was
not possible to test this hypothesis. This overview did
however, find that home telemonitoring in heart failure
can lead to reductions in hospitalisation and readmission
rates, whilst also increasing visits to outpatients and
home visits thus suggesting a possible redirection of
healthcare usage, rather than an elimination. For any
economic assessment, this will only be financially advan-
tageous if the cost of providing care in outpatient ser-
vices and home visits was less than hospitalisation.
Although it is likely that this is the case [46], further ex-
ploration of this issue is needed.
In two of the included reviews [31, 32], the interven-
tions focused on patients contacting a healthcare profes-
sional in response to their monitored symptoms. This
would by definition increase healthcare usage, however
the outcomes in both reviews were either hospitalisation
or readmission rates suggesting that this additional con-
tact with healthcare services in response to the moni-
tored data was not considered as an outcome, but part
of the intervention. Whilst one of these reviews [32]
failed to find an effect for action planning on hospital
admissions, A & E attendance or GP visits. The signifi-
cant reduction in disease-specific and all-cause readmis-
sion reported in the other review [31] could therefore be
a result of a redirection of care to telephone based care,
rather than an elimination of healthcare usage. This rela-
tionship however, requires further exploration.
The findings of this overview need to be interpreted
within the context of the specific chronic condition, as
the purpose of self-monitoring, the data monitored and
the manner in which healthcare usage was targeted as
an outcome, differs between conditions. In hypertension
the primary purpose of self-monitoring blood pressure is
to increase adherence to hypertensive medication, re-
duce clinical inertia and provide information about the
efficacy of treatment. Guidelines from the European So-
ciety of Hypertension [47] suggest that home blood pres-
sure monitoring is suitable for any patient wanting to
contribute to their own management. Data is however
passed to a healthcare professionals to interpret and if
necessary alter medication dosage. As hypertension is
managed largely in primary care, these reviews assessed
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the effects on primary care usage only. In contrast, the
guidelines for the management of COPD [48] state that
patients at risk of having an exacerbation should be
given advice that encourages them to respond promptly
to the symptoms of an exacerbation, by starting oral cor-
ticosteroids or antibiotic treatment, or adjusting their
bronchodilator therapy to control their symptoms. In
heart failure, frequent monitoring alerts clinicians to the
signs and symptoms of decline, providing the opportun-
ity for intervention prior to the patient becoming ser-
iously ill and needing hospitalisation. Guidelines in the
UK and Europe [49–51] recommend that self-monitoring
should be part of the treatment of heart failure, by patients
monitoring and recognising symptoms, signs and weight
gain, and recording daily weight. Patients should then
be given the relevant information to know when and
how to notify their healthcare professional or self-
adjust their diuretic therapy. What is considered vital is
an immediate response to these signs and symptoms,
which can herald clinical deterioration and thereby
avoid hospitalisation. In contrast to the reviews on
hypertension which focussed only on primary care as
an outcome, the reviews in both COPD and heart fail-
ure, primarily focused on the use of secondary care
services.
As highlighted elsewhere in the literature [2] it is also
important to note that healthcare utilisation is not al-
ways patient-led, but often initiated by healthcare profes-
sionals. Initiation by a healthcare professional does
however, not negate the possibility that self-monitoring
can lead to reductions in healthcare usage. Linked to this
is the notion that engaging and empowering patients
with a chronic condition to adjust their treatment and
lifestyle themselves in response to monitored data, may
be a more successful route to improving outcomes as op-
posed to the healthcare professional leading this decision.
Although this is a process that has been fostered primarily
in COPD treatment guidelines, only one review within this
overview [32] explicitly stated that patients with COPD
were involved in adjusting their medication and this was
only in a subset of the primary research studies. The clin-
ical benefits of empowering patients, rather than health-
care professionals, to interpret their monitored data and
adjust accordingly remains uncertain [52–55]. The two re-
views in this overview that included interventions with all
three components of self-monitoring: awareness, inter-
pretation and adjustment [6, 7] did not exhibit consistent
findings. Hence, further work is needed to understand,
the potential benefits, in relation to both clinical out-
comes and healthcare usage, of patients being involved
and leading on adjusting their own treatment in re-
sponse to monitored data.
It is unlikely that self-monitoring was implemented in
isolation within these interventions, however information
on the inclusion of other behaviour change techniques
were missing. Lack of detail is common in the description
of complex interventions, constraining scientific repli-
cation and limiting the subsequent introduction of suc-
cessful interventions [56]. This review has assumed that
self-monitoring was an important component of all of
the interventions however, without a detailed descrip-
tion of the other behaviour change techniques used, it
is not possible to say unequivocally that this was the
key behavioural component. Future work would benefit
from coding intervention descriptions using the recently
developed Behaviour Change Technique Taxonomy
(BCTTv1) [4], which enables a detailed description of
intervention content according to 93 theoretically de-
rived techniques and may allow for a more systematic
analysis of which techniques are more effective in im-
proving outcomes.
Overviews of reviews bring together all of the system-
atic reviews and meta-analyses in the area in order to
provide a summary of the evidence. There are however,
several limitations that should be acknowledged. The
weight given to heart failure in this overview, as a result
of the number of reviews in this area, may limit the
generalizability of the results across chronic conditions.
As with any overview of secondary data, this review re-
lies on the quality of the reporting found in not only the
reviews themselves, but also the primary research studies
included within them. The overall quality of the system-
atic reviews and meta-analyses was good, but with sig-
nificant variation. In addition a high quality review may
contain poor quality evidence, or even limited evidence,
because that is all that is available. Therefore, assessment
of the quality of the primary research studies within each
review was important. Despite this, integration of study
quality into the conclusions and recommendations was
undertaken in less than half of all reviews and even
when quality was assessed in many cases it was evalu-
ated as poor. Finally, the inclusion of primary research
studies in more than one systematic review or meta-
analyses may have unduly influenced the overall conclu-
sions of this overview. There was however, only slight
overlap within this overview, but this did vary quite sig-
nificantly between chronic conditions, with no overlap
in COPD and a very high level of overlap in hyperten-
sion. The more diverse the interventions within a condi-
tion the lower the degree of overlap. A high degree of
overlap may reflect an unnecessary duplication of re-
views [24]. Due to the number of retrieved articles one
notable limitation to this overview is that only one au-
thor reviewed article titles in the first stage of review se-
lection, which may have introduced selection bias.
Despite these limitations, this article attempts to inte-
grate conclusions regarding self-monitoring across a
number of long-term conditions and synthesizes both
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systematic reviews and meta-analyses. The findings of
this overview do however, need to be considered in light
of the overall quality of the reviews, which varied signifi-
cantly. Nonetheless it provides a useful synthesis of find-
ings on the role of self-monitoring in chronic illness.
Conclusions
To accompany the published clinical benefits of self-
monitoring, this overview found that self-monitoring
can lead to significant reductions in hospitalisation and
readmission to hospital, specifically in heart failure and
COPD. There was however, evidence to suggest that
these reductions may lead to increase in services else-
where in the healthcare system. Further work is needed
to evaluate the extent to which this redirection of ser-
vices affects healthcare costs. These results need to be
interpreted in light of the variation in not only the qual-
ity of the systematic reviews themselves, but also the pri-
mary research papers included within them, which also
varied significantly. Future studies, both primary re-
search studies and reviews, need to better describe inter-
vention content in order to understand the impact of
specific components of self-management.
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